Nicholas Barrie La Thangue (Nick B La Thangue, Nicholas B La Thangue)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Transforming Growth Factor

Regulatory T Cells

Protein Protein

Top Venues

Nature communications

Cell death & disease

Communications biology

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Laurel Tabe Bate-Eya, Gulsah Albayrak, Simon Mark Carr, Amit Shrestha, Alexander Kanapin, Anastasia Samsonova, Nicholas Barrie La Thangue
Sustained cancer-relevant alternative RNA splicing events driven by PRMT5 in high-risk neuroblastoma. Molecular oncology (2024)
Wojciech Barczak, Simon Mark Carr, Geng Liu, Shonagh Munro, Annalisa Nicastri, Lian Ni Lee, Claire Hutchings, Nicola Ternette, Paul Klenerman, Alexander Kanapin, Anastasia Samsonova, Nicholas Barrie La Thangue
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nature communications 14 (1) (2023)
Geng Liu, Wojciech Barczak, Lian Ni Lee, Amit Shrestha, Nicholas M Provine, Gulsah Albayrak, Hong Zhu, Claire L Hutchings, Paul Klenerman, Nicholas Barrie La Thangue
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity. Communications biology 6 (1) (2023)
Koyo Harada, Simon Mark Carr, Amit Shrestha, Nicholas Barrie La Thangue
Citrullination and the protein code: crosstalk between post-translational modifications in cancer. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 378 (1890) (2023)
Geng Liu, Wojciech Barczak, Lian Ni Lee, Amit Shrestha, Nicholas M Provine, Gulsah Albayrak, Hong Zhu, Claire L Hutchings, Paul Klenerman, Nicholas Barrie La Thangue
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity. Communications biology 6 (1) (2023)
Eunji Hong, Wojciech Barczak, Sujin Park, Jin Sun Heo, Akira Ooshima, Shonagh Munro, Chang Pyo Hong, Jinah Park, Haein An, Joon Oh Park, Seok-Hee Park, Nicholas Barrie La Thangue, Seong-Jin Kim
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors. Cell death & disease 14 (2) (2023)
Wojciech Barczak, Simon Mark Carr, Geng Liu, Shonagh Munro, Annalisa Nicastri, Lian Ni Lee, Claire Hutchings, Nicola Ternette, Paul Klenerman, Alexander Kanapin, Anastasia Samsonova, Nicholas Barrie La Thangue
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nature communications 14 (1) (2023)
Geng Liu, Wojciech Barczak, Lian Ni Lee, Amit Shrestha, Nicholas M Provine, Gulsah Albayrak, Hong Zhu, Claire L Hutchings, Paul Klenerman, Nicholas Barrie La Thangue
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity. Communications biology 6 (1) (2023)
Wojciech Barczak, Simon Mark Carr, Geng Liu, Shonagh Munro, Annalisa Nicastri, Lian Ni Lee, Claire Hutchings, Nicola Ternette, Paul Klenerman, Alexander Kanapin, Anastasia Samsonova, Nicholas Barrie La Thangue
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nature communications 14 (1) (2023)
Wojciech Barczak, Simon Mark Carr, Geng Liu, Shonagh Munro, Annalisa Nicastri, Lian Ni Lee, Claire Hutchings, Nicola Ternette, Paul Klenerman, Alexander Kanapin, Anastasia Samsonova, Nicholas Barrie La Thangue
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nature communications 14 (1) (2023)
Wojciech Barczak, Simon Mark Carr, Geng Liu, Shonagh Munro, Annalisa Nicastri, Lian Ni Lee, Claire Hutchings, Nicola Ternette, Paul Klenerman, Alexander Kanapin, Anastasia Samsonova, Nicholas Barrie La Thangue
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nature communications 14 (1) (2023)
Eunji Hong, Wojciech Barczak, Sujin Park, Jin Sun Heo, Akira Ooshima, Shonagh Munro, Chang Pyo Hong, Jinah Park, Haein An, Joon Oh Park, Seok-Hee Park, Nicholas Barrie La Thangue, Seong-Jin Kim
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors. Cell death & disease 14 (2) (2023)
Geng Liu, Wojciech Barczak, Lian Ni Lee, Amit Shrestha, Nicholas M Provine, Gulsah Albayrak, Hong Zhu, Claire L Hutchings, Paul Klenerman, Nicholas Barrie La Thangue
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity. Communications biology 6 (1) (2023)
Eunji Hong, Wojciech Barczak, Sujin Park, Jin Sun Heo, Akira Ooshima, Shonagh Munro, Chang Pyo Hong, Jinah Park, Haein An, Joon Oh Park, Seok-Hee Park, Nicholas Barrie La Thangue, Seong-Jin Kim
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors. Cell death & disease 14 (2) (2023)
Eunji Hong, Wojciech Barczak, Sujin Park, Jin Sun Heo, Akira Ooshima, Shonagh Munro, Chang Pyo Hong, Jinah Park, Haein An, Joon Oh Park, Seok-Hee Park, Nicholas Barrie La Thangue, Seong-Jin Kim
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors. Cell death & disease 14 (2) (2023)
Wiktoria Blaszczak, Geng Liu, Hong Zhu, Wojciech Barczak, Amit Shrestha, Gulsah Albayrak, Shunsheng Zheng, David Kerr, Anastasia Samsonova, Nicholas Barrie La Thangue
Immune modulation underpins the anti-cancer activity of HDAC inhibitors. Molecular oncology 15 (12) (2021)
Alice Poppy Roworth, Simon Mark Carr, Geng Liu, Wojciech Barczak, Rebecca Louise Miller, Shonagh Munro, Alexander Kanapin, Anastasia Samsonova, Nicholas Barrie La Thangue
Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control. Science advances 5 (6) (2019)